Related Experiment Video
Updated: Dec 23, 2025

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
Regulatory landscape of dietary supplements and herbal medicines from a global perspective
Shraddha Thakkar1, Elke Anklam2, Alex Xu3
1National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.
Abstract:
The number of Individuals that use dietary supplements and herbal medicine products are continuous to increase in many countries. The context of usage of a dietary supplement varies widely from country-to-country; in some countries supplement use is just limited to general health and well-being while others permit use for medicinal purposes. To date, there is little consensus from country to country on the scope, requirements, definition, or even the terminology in which dietary supplement and herbal medicines categories could be classified. Transparent science-based quality standards for the ingredients across these regulatory frameworks/definitions becomes even more important given the international supply chain. Meanwhile, there has been a rapid advancement in emerging technologies and data science applied to the field. This review was conceived at the Global Summit on Regulatory Sciences that took place in Beijing on September 2018 (GSRS2018) which is organized by Global Coalition for Regulatory Science Research (GCRSR) that consists of the global regulatory agencies from over ten countries including the European Union. This review summarizes a significant portion of discussions relating to a longitudinal comparison of the status for dietary supplements and herbal medicines among the different national jurisdictions and to the extent of how new tools and methodologies can improve the regulatory application.
More Related Videos
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Global Regulatory Systems
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Classes and Categories
Dosage Regimen: Individualization

